Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OxStem Ltd.

www.oxstem.co.uk

Latest From OxStem Ltd.

Start-Up Quarterly Statistics, Q2 2016

A review of biopharma start-up dealmaking and financing from April through June 2016, based on data from Strategic Transactions.

Financing Deals

Venture Funding Deals, July 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced May through June.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Neurology, Nervous System
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • OxStem Ltd.
  • Senior Management
  • Michael Stein, MD, CEO
    Raymond Spencer, CFO
  • Contact Info
  • OxStem Ltd.
    Midland House, West Way
    Botley
    Oxford, OX2 0PH
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register